Due to the urgency placed on immediate manufacturing of Retrovir, production of capsules went ahead immediately. Doug Faulkner from the Quality Assurance department explains how the first batch had to meet standards, and pass 300 analyses. Jeff Waddingham, the Retrovir Supplies Coordinator, describes how orders were processed immediately, how package design could be adapted for different coountries and how distribution to different countries worked. The voiceover explains how usually, a new drug being put onto the market takes about three years, but Retrovir took just six months. All the previously seen Wellcome staff discuss what a challenge this process was and how proud they are to have completed it in time. A note from the Wellcome Trust is shown at the end thanking all the staff who made the introduction of Retrovir a success.